Author

Sabrina I. Jarrah

University of Michigan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 2 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 3 Approach:experimental assay· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Assay:proteomics· 1 Assay:snRNA-seq· 1

Frequent Co-Authors

Hayley S. McLoughliniD· 3 shared Kristen H. SchusteriD· 2 shared Albert R. La SpadaiD· 1 shared Alexandra F. PutkaiD· 1 shared Annie J. Zalon· 1 shared Arsal Naeem· 1 shared Court HulliD· 1 shared Craig B. LoweiD· 1 shared

Activity by Year

2023-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersNeuroscience

Hayley S. McLoughlinORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

NeuroscienceMolecular TherapyPeer-reviewedFeb 29, 2024

ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice

Kristen H. Schuster, Annie J. Zalon, Danielle M. DiFranco…·Hayley S. McLoughlin

This study shows that ASO treatment rescues oligodendrocyte dysfunction in SCA3 mice by targeting mutant ATXN3, suggesting potential for glial-targeted therapies in neurodegenerative diseases.

24 citations

mouseexperimental assay

𝕏 PostBluesky

GenomicsbioRxivPreprintMar 19, 2023

Purkinje-Enriched snRNA-seq in SCA7 Cerebellum Reveals Zebrin Identity Loss as a Central Feature of Polyglutamine Ataxias

Luke C. Bartelt, Pawel Michal Switonski, Grażyna Adamek…·Albert R. La Spada

The paper uses snRNA-seq to study Purkinje cells in SCA7 mice, revealing zebrin-II subtype loss as a key feature of polyglutamine ataxias.

7 citations

mousesnRNA-seq

𝕏 PostBluesky

NeurosciencebioRxivPreprintFeb 28, 2023

Blood neurofilament light chain levels are associated with disease progression in a transgenic SCA3 mouse model

David Mengel, Isabel G. Wellik, Kristen H. Schuster…·Hayley S. McLoughlin

The paper measures blood neurofilament light chain (NfL) levels in a transgenic SCA3 mouse model and finds they correlate with disease progression and severity.

DOI 10.1101/2023.02.28.530463

mouseproteomics

𝕏 PostBluesky